The Floow Limited has been acquired by Otonomo Technologies Ltd.
Direct Line Insurance Group plc has sold The Floow Limited, a software as a service (SaaS) global provider of connected insurance technology for major carriers, to Otonomo Technologies, the mobility intelligence company.
The Floow is a pioneer in the use of advanced data analytics that sits behind blue-chip insurers-connected automotive insurance policies that effectively prices on driving behavior and usage, rather than more typical demographics.
Located in Israel, Otonomo Technologies is a cloud-based SaaS platform for the vehicle data exchange.
Oaklins Cavendish, based in the UK, advised on the sale of The Floow Limited.



Aldo Monteforte
CEO, The Floow Limited
Talk to the deal team
Related deals
BodhiCedric has acquired Network Media from Jellysmack
The media holding company BodhiCedric has acquired Network Media, an innovator in the creator economy, from Jellysmack, the global creator company.
Learn moreCustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions
Bengaluru-based SaaS firm Perfios Software Solutions Private Ltd. has acquired 100% of the equity shares in the fraud-detection platform CustomerXPs Software Private Ltd. (Clari5) for an undisclosed amount, enhancing its anti-financial crime management suite for financial institutions.
Learn moreBayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn more